The high-ITGA3 group exhibited higher neoantigen loads (P < 0.05, Fig. 7C), cell components (CC) in T cell receptor complex and immunoglobulin complex (Fig. 7D), molecular function (MF) in antigen binding (Fig. 7E), and tumor mutational burden (P < 0.01, Fig. 7F) in high-ITGA3 samples. This evidence concerns the gene ITGA3 and neoplasm.